Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Grindelia Rub, Ipecac, Blatta Ori, Lobellia Inf, Drosera, Bryonia Alb, Justisia Adh
Brand Name
Bestmade Natural Products Bm109
Generic Name
Grindelia Rub, Ipecac, Blatta Ori, Lobellia Inf, Drosera, Bryonia Alb, Justisia Adh
Active Ingredient
Blatta OrientalisCategory
Non-Standardized Insect Allergenic Extract [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 30 [hp_C]/30[hp_C] | LIQUID | ORAL | 82969-2109 |
Detailed information about Bestmade Natural Products Bm109
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Bestmade Natural Products Bm109, you must consult a qualified healthcare professional.
Blatta Orientalis is a non-standardized insect allergenic extract used primarily for the diagnosis and treatment of cockroach-induced allergic rhinitis and asthma. It belongs to the class of insect allergenic extracts and works by modulating the immune system's response to specific allergens.
Dosage for Blatta Orientalis is highly individualized and must be determined by an allergist or immunologist based on the patient's sensitivity level. The treatment is divided into two phases:
This phase begins with a very low concentration (often a 1:100,000 or 1:10,000 w/v dilution). Injections are typically given 1 to 2 times per week. The dose is gradually increased at each visit, provided the patient does not experience significant local or systemic reactions. The build-up phase usually lasts 3 to 6 months.
Once the 'maintenance dose' is reached—this is the highest dose that the patient can tolerate without a significant reaction—the frequency of injections is reduced. Maintenance injections are typically administered every 2 to 4 weeks. The maintenance dose for Blatta Orientalis often ranges from 0.1 mL to 0.5 mL of the most concentrated vial (e.g., 1:10 or 1:20 w/v).
Blatta Orientalis is used in children, particularly those with cockroach-sensitized asthma. Dosing principles are similar to adults, but the starting dose may be even more conservative depending on the child's age and the severity of their asthma. Clinical studies have shown that immunotherapy can be effective in children as young as 5 years old. However, the decision to start immunotherapy in very young children (under 5) requires a careful risk-benefit analysis by a pediatric allergist.
No specific dosage adjustments are typically required for patients with renal impairment, as the allergenic proteins are not primarily cleared by the kidneys in their active form. However, the patient's overall health should be considered before starting immunotherapy.
No dosage adjustments are necessary for hepatic impairment. The metabolism of allergenic proteins occurs through general proteolytic pathways rather than specific hepatic enzyme systems (like CYP450).
Elderly patients may be at higher risk for complications if a systemic reaction occurs, especially if they have underlying cardiovascular disease. Healthcare providers may use more cautious dosing increments and monitor these patients more closely.
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated, depending on how much time has passed. If a maintenance dose is missed by more than a few weeks, the allergist will typically reduce the dose for the next injection to ensure safety and then gradually build back up to the maintenance level.
An overdose of Blatta Orientalis occurs if a dose is given that is too high for the patient's current level of tolerance. Symptoms of an overdose are essentially the symptoms of a severe allergic reaction, including:
In the event of an overdose, emergency treatment with epinephrine is required immediately. Most clinics follow a standardized protocol for managing anaphylaxis induced by immunotherapy.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Always inform your doctor if you have had a reaction to a previous injection.
Most patients undergoing immunotherapy with Blatta Orientalis will experience some form of local reaction at the site of the injection. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Blatta Orientalis and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' side effects of Blatta Orientalis, as it is a biological protein extract. The primary long-term risk is the development of a new sensitivity or the persistence of the original allergy if the therapy is not successful. Some patients may develop small, firm nodules under the skin at the injection site (granulomas) if aluminum-adsorbed extracts are used over a long period; these are generally harmless.
While Blatta Orientalis itself may not have a specific 'Black Box Warning' on every manufacturer's label, the class of allergenic extracts carries a general warning regarding the risk of severe systemic reactions.
FDA Class Warning Summary: Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylactic shock and death. They should only be administered by physicians who are exceptionally experienced in the treatment of allergic diseases and the management of systemic reactions. Patients with unstable or severe asthma are at a higher risk for these reactions. All patients must be observed for at least 30 minutes following administration.
Report any unusual symptoms to your healthcare provider. Your doctor may suggest taking an antihistamine before your appointment to reduce the risk of minor local reactions.
Blatta Orientalis is a potent biological product. It is intended for use only by clinicians specialized in allergy and immunology. The most critical safety consideration is the potential for an IgE-mediated systemic reaction. Patients must be in their baseline state of health before receiving an injection. If you are experiencing an asthma flare-up or have a fever, your injection should be postponed.
No specific FDA black box warnings are currently issued specifically for the Blatta Orientalis name, but the general class of Allergenic Extracts contains a warning regarding the risk of anaphylaxis. This warning emphasizes that the product must be administered in a setting where emergency equipment (including epinephrine, oxygen, and IV fluids) is immediately available.
There are no standard laboratory tests (like blood counts) required for Blatta Orientalis. However, clinical monitoring is rigorous:
Blatta Orientalis generally does not affect the ability to drive or operate machinery. However, if a patient experiences a systemic reaction or feels faint after an injection, they should not drive until they are fully recovered and cleared by a medical professional.
There is no direct interaction between Blatta Orientalis and alcohol. However, alcohol can cause vasodilation and might theoretically increase the speed of allergen absorption or mask the early symptoms of an allergic reaction. It is generally advised to avoid heavy alcohol consumption on the day of an injection.
Immunotherapy can be discontinued at any time, but stopping prematurely (before 3 years) often results in the return of allergic symptoms. There is no 'withdrawal syndrome' associated with stopping Blatta Orientalis, as it is not a physically addictive substance. If you wish to stop treatment, discuss a plan with your allergist.
> Important: Discuss all your medical conditions, including any history of heart disease or severe asthma, with your healthcare provider before starting Blatta Orientalis.
There are no known direct food interactions with Blatta Orientalis. However, patients with 'Oral Allergy Syndrome' or multiple food allergies should be stable before receiving their injections. It is also recommended to avoid large, heavy meals immediately before or after an injection to ensure that any gastrointestinal symptoms felt are not confused with an allergic reaction.
There is limited data on herbal interactions. However, supplements that have 'anti-inflammatory' or 'immune-boosting' claims (such as Echinacea or high-dose Astragalus) should be discussed with an allergist, as they could theoretically interfere with the immune-modulating goals of the therapy.
Blatta Orientalis treatment will affect the results of specific allergy tests:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any medications for blood pressure or heart conditions.
Blatta Orientalis must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients allergic to Blatta Orientalis (Oriental Cockroach) often show cross-sensitivity to other cockroach species, such as Blattella germanica (German Cockroach). There is also some evidence of cross-reactivity with other invertebrates, such as shellfish (shrimp, crab) and dust mites, due to shared proteins like tropomyosin. Patients with known severe shellfish allergies should be skin-tested with caution.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Blatta Orientalis.
Pregnancy Category C: Blatta Orientalis has not been studied in pregnant women to determine its effects on the fetus. The primary risk during pregnancy is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis) in the mother. Anaphylaxis can lead to a sudden drop in blood pressure and oxygen levels, which can cause fetal distress or death.
It is not known whether the components of Blatta Orientalis are excreted in human milk. However, since the extract consists of naturally occurring proteins that are degraded into amino acids, it is highly unlikely to pose a risk to a nursing infant. Most experts consider immunotherapy compatible with breastfeeding.
Blatta Orientalis is widely used in children sensitized to cockroach allergens. It is particularly beneficial for children with 'urban asthma.' Studies indicate that immunotherapy can prevent the development of new sensitivities and may reduce the risk of progressing from allergic rhinitis to asthma. Dosing must be cautious, and the child must be able to cooperate with the 30-minute observation period.
Clinical studies of allergenic extracts generally do not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. In elderly patients, the decision to use Blatta Orientalis must consider the higher prevalence of comorbid conditions like hypertension and coronary artery disease, which increase the risk associated with systemic reactions.
There is no evidence that renal impairment significantly alters the safety or efficacy of Blatta Orientalis. Because the treatment involves immunological modulation rather than systemic drug levels, standard GFR-based adjustments are not applicable. However, clinicians should ensure the patient is stable enough to tolerate a potential systemic reaction.
No specific studies have been conducted in patients with hepatic impairment. Given the proteolytic metabolism of the extract, liver function is not expected to impact the clearance of the drug. Dose adjustments are not required based on Child-Pugh classification.
> Important: Special populations require individualized medical assessment. Always inform your allergist if you are pregnant, planning to become pregnant, or have underlying health issues.
Blatta Orientalis extract acts as an immunomodulator. Its primary mechanism is the induction of peripheral T-cell tolerance. This is achieved through several pathways:
| Parameter | Value |
|---|---|
| Bioavailability | Low (Subcutaneous absorption is slow and local) |
| Protein Binding | N/A (Consists of proteins that interact with receptors) |
| Half-life | Days (Proteins), Years (Immunological memory) |
| Tmax | 1 - 2 hours (for systemic absorption of small amounts) |
| Metabolism | Proteolytic degradation by tissue enzymes |
| Excretion | Renal (as amino acids/peptides) |
Blatta Orientalis is classified as a Non-Standardized Insect Allergenic Extract [EPC]. It is part of the broader category of biologicals used for allergen-specific immunotherapy. Related medications include extracts for Blattella germanica (German Cockroach) and various Hymenoptera (venom) extracts, although the latter are typically standardized.
Common questions about Bestmade Natural Products Bm109
Blatta Orientalis extract is primarily used for the diagnosis and treatment of allergies to the Oriental cockroach. In diagnostic settings, it is used in skin prick tests to confirm if a patient has an IgE-mediated sensitivity to these insects. Therapeutically, it is used in allergen immunotherapy (allergy shots) to help desensitize the patient's immune system over time. This is especially helpful for patients with chronic asthma or allergic rhinitis who live in environments where cockroach exposure is high. The goal is to reduce the severity of allergic symptoms and decrease the need for daily rescue medications.
The most common side effects are local reactions at the site of the injection, occurring in nearly all patients at some point during treatment. These include redness, swelling, itching, and mild soreness where the shot was given. These symptoms usually appear shortly after the injection and resolve within a day or two. Some patients may also experience a 'large local reaction,' where the swelling exceeds two inches in diameter. While these are common and generally not dangerous, they should be reported to your doctor so they can adjust your next dose if necessary.
There is no known direct chemical interaction between alcohol and Blatta Orientalis extract. However, most allergists recommend avoiding significant alcohol consumption on the day of your injection. Alcohol can cause your blood vessels to dilate, which might theoretically speed up the absorption of the allergen into your bloodstream, potentially increasing the risk of a systemic reaction. Additionally, being under the influence of alcohol can make it harder for you to notice or accurately describe early symptoms of an allergic reaction, such as itching or lightheadedness.
Blatta Orientalis is generally not started during pregnancy because the risk of a severe allergic reaction (anaphylaxis) could be dangerous for both the mother and the developing fetus. Anaphylaxis can cause a sharp drop in blood pressure, leading to reduced oxygen flow to the placenta. However, if a woman is already on a stable maintenance dose and is tolerating the injections well, most healthcare providers will continue the treatment throughout pregnancy. The decision is always based on a careful discussion between the patient and her allergist regarding the risks and benefits.
Allergen immunotherapy is a long-term treatment process and does not provide immediate relief like an antihistamine or a rescue inhaler. Most patients begin to notice a reduction in their allergy or asthma symptoms toward the end of the 'build-up' phase, which typically takes 3 to 6 months. Significant and lasting improvement usually requires 12 months of consistent treatment. For the best results and long-term protection even after the shots are stopped, a full course of 3 to 5 years is generally recommended by clinical guidelines.
Yes, you can stop taking Blatta Orientalis injections suddenly without experiencing a physical withdrawal syndrome, as it is not a habit-forming medication. However, stopping the treatment before the recommended 3-to-5-year course is completed often means that your allergy symptoms will eventually return. The immune system requires a long period of exposure to the extract to develop permanent tolerance. If you find the injection schedule difficult to maintain, talk to your doctor about possible adjustments before deciding to discontinue the treatment entirely.
If you miss a dose of Blatta Orientalis, you should contact your allergist's office to reschedule as soon as possible. The procedure for a missed dose depends on how long it has been since your last injection and whether you are in the build-up or maintenance phase. If only a few days have passed, you may be able to continue with your scheduled dose. If several weeks have passed, your doctor will likely need to reduce the dose for your next injection to ensure safety and then gradually increase it again. Never try to 'double up' on a dose to make up for a missed one.
There is no clinical evidence to suggest that Blatta Orientalis allergenic extract causes weight gain. The extract consists of small amounts of proteins and glycoproteins that work locally on the immune system and do not affect your metabolism, appetite, or fat storage. If you experience weight changes while on immunotherapy, they are likely due to other factors, such as lifestyle changes or other medications you may be taking (like oral steroids for asthma). Always discuss unexpected weight changes with your primary care physician.
Blatta Orientalis can be taken alongside most common allergy and asthma medications, such as antihistamines, leukotriene modifiers (like Singulair), and inhaled corticosteroids. In fact, these medications are often necessary to keep your symptoms controlled during the build-up phase. However, it is critical to tell your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make allergic reactions more dangerous or harder to treat. Your allergist will coordinate your treatment to ensure all your medications are compatible.
Blatta Orientalis is a biological extract rather than a synthetic drug, so the term 'generic' does not apply in the traditional sense. However, it is produced by several different biological laboratories (such as Greer, ALK, or HollisterStier). While these extracts are all derived from the same cockroach species, they are 'non-standardized,' meaning the exact protein concentration can vary slightly between manufacturers. For this reason, allergists prefer not to switch between different brands of the extract once a patient has started their treatment to ensure consistency in dosing.
Other drugs with the same active ingredient (Blatta Orientalis)